IRVINE, Calif., Sept. 8 /PRNewswire-FirstCall/ -- BioLargo, Inc. (OTC:BLGO) (BULLETIN BOARD: BLGO) , a company engaged in pre-licensing and product evaluation, today announced that the company's President and CEO, Dennis Calvert, is featured in an exclusive interview on WallSt.net's 3-Minute Press Show. The interview gives viewers an overview of the company, and the significance of the company's latest press release. To view the clip in its entirety, visit: http://www.tv.wallst.net/r/3-minute-press/BioLargo/239/983 About BioLargo, Inc.: BioLargo, Inc. is currently engaged in pre-licensing and product evaluation with strategic partners to leverage a suite of patented and patent-pending intellectual property, the BioLargo technology. The BioLargo technology harnesses and delivers nature's best disinfectant -- iodine -- in a safe, efficient, environmentally sensitive and cost-effective manner. The BioLargo technology, the centerpiece of which is CupriDyne(TM), works by combining minerals and salts with water from any source to generate and deliver molecular iodine on demand, in controlled dosages, in order to balance efficacy of disinfectant performance with concerns about toxicity. When the BioLargo technology is incorporated in absorbent products, third-party testing has confirmed that the products also experience increased holding power, and the company believes that they may also experience increased absorption. The company's website is http://www.biolargo.com/. About WallStreet Direct, Inc. WallStreet Direct, Inc. operates WallSt.net (http://www.wallst.net/), a leading source of up-to-the-minute business news, comprehensive financial tools and original multimedia content for the investment community. In addition to WallSt.net, WallStreet Direct owns and operates WallStRadio (http://radio.wallst.net/), an online hub for business podcasts from well-known business news personalities and publishers, and WallStTV (http://tv.wallst.net/), a hub for business and finance video content. We have received two hundred eighty dollars from BioLargo, Inc. for the dissemination of this press release. To read our full disclaimer, and for a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.php. Contact: WallStreet Direct, Inc. 800-4-WALLST DATASOURCE: BioLargo, Inc.; WallStreet Direct, Inc. CONTACT: WallStreet Direct, Inc., 1-800-4-WALLST Web site: http://www.biolargo.com/ http://www.wallst.net/

Copyright